effect nisoldipin myocardi ischemia exercis daili activ antiischem properti nisoldipin dihydropyridin calcium antagonist multicent double-blind placebo-control trial exercis ambulatori electrocardiograph monitor patient coronari arteri diseas patient posit treadmil stress test result equal ischem episod hour studi administr chronic antiischem medic beta blocker first week patient placebo second third week patient nisoldipin mg patient placebo placebo group chang exercis paramet ambulatori electrocardiograph paramet nisoldipin group exercis durat second time mm ST depress second time second maxim ST depress mm ambulatori electrocardiograph paramet nisoldipin group number episod patient signific reduct total ischem time vs minut patient signific side effect clinic trial date effect nisoldipin myocardi ischemia result nisoldipin effect exercis paramet effect ischemia daili activ 